For a patient newly diagnosed with cancer, it's important that they make sure they educate themselves on their disease and all of their options, explained Janice Mehnert, MD, Head of the Phase I Developmental Therapeutics Program at Rutgers Cancer Institute of New Jersey.
For a patient newly diagnosed with cancer, it's important that they make sure they educate themselves on their disease and all of their options, explained Janice Mehnert, MD, Head of the Phase I Developmental Therapeutics Program at Rutgers Cancer Institute of New Jersey.
If you could recommend one thing to a patient newly diagnosed with cancer, what would it be?
It’s important for patients to understand that when you’re planning your cancer care, it’s really important to make sure that [while] you’re a participant in this journey that you’re comfortable in this journey, more important than getting your diagnosis and getting your infusion two weeks later, which every patient always wants … When a patient hears “You have cancer,” and needs systemic treatment. The next question is always, “Well, when am I going to get started?” [But] if I could impress something on patients, it’s much more important—for the most part—to take that time to educate yourself about the disease, get a good education get another opinion, seek out a clinical trial consultation. That’s critical because that’s the only time you’re really ever able to do that. There are a few cases where it’s a true emergency to initiate therapy. Seeking multi op seeking expert consultations and seeking trial offerings is really empowering to patients. If I were to have a dream policy change that would something that would be mandatory for every patient who has a diagnosis of cancer. Especially with immunotherapy—we wouldn’t be here if it wasn’t for clinical research. And understanding that now we’re just going to improve upon the existing advancements, but we still need to have those expert consultations and those expert collaborations. I think patients should know that.
New Insights Into Meth-Associated PAH Care Gaps: Anjali Vaidya, MD, on Closing the Divide
June 4th 2025Research from Anjali Vaidya, MD, FACC, FASE, FACP, Temple University Hospital, reveals critical care gaps for patients with methamphetamine-associated pulmonary arterial hypertension (PAH), emphasizing the need for early diagnosis and integrated support.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Tailored Dosing for MM Matters More Than Drug Count: Ajai Chari, MD
April 25th 2025When it comes to treating multiple myeloma (MM), Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't necessarily guarantee better outcomes.
Read More
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More